Aaron L Schacht
CIK 1752460 · View on SEC EDGAR ↗
First SEC filing: March 3, 2021 · Latest: March 3, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 11, 2019 | ELAN | P | 1,227 | — | — | 13,924 Direct | +9.66% | Acquired | (price as of 2026-08-21) |
| Sept. 24, 2018 | ELAN | P | 400 | $24.00 | $9,600 | 400 Direct | — | Acquired | 0.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 20, 2018 | ELAN | Non-Qualified Stock Option (Right-to-Buy) | Elanco Animal Health Inc. Common Stock (21,086) | $31.61 | Oct. 20, 2028 | 21,086 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ELAN
President, Innovation, Regulatory and Business Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $609,000 | — | $1,859,028 | — | $562,716 | — | $1,087,226 | $4,117,970 |
| 2020 | — | — | — | — | — | — | — | — |
| 2019 | $434,167 | $0 | $2,101,855 | $0 | $270,920 | — | $19,367 | $2,826,309 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.